Low-dose aspirin discontinuation and risk of cardiovascular events: a Swedish nationwide, population-based cohort study
J Sundström, J Hedberg, M Thuresson, P Aarskog… - Circulation, 2017 - Am Heart Assoc
Background: There are increasing concerns about risks associated with aspirin
discontinuation in the absence of major surgery or bleeding. We investigated whether long …
discontinuation in the absence of major surgery or bleeding. We investigated whether long …
Improving adherence to medication for secondary cardiovascular disease prevention
J Keenan - European journal of preventive cardiology, 2017 - academic.oup.com
Survivors of myocardial infarction are at risk of recurrent events and have an annual death
rate of 5%. Advances in treatment and, in particular, the interventional management of …
rate of 5%. Advances in treatment and, in particular, the interventional management of …
Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy …
R Pitts, SL Daugherty, F Tang, P Jones… - Clinical …, 2017 - Wiley Online Library
Background Patients with acute myocardial infarction (AMI) and nonobstructive coronary
artery disease (nonobCAD) may be perceived to be at lower risk for cardiac events, relative …
artery disease (nonobCAD) may be perceived to be at lower risk for cardiac events, relative …
Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
Y Sun, C Li, L Zhang, D Hu, X Zhang, T Yu, M Tao… - Frontiers of …, 2017 - Springer
Low adherence to secondary prevention medications (ATM) of patients after acute coronary
syndrome (ACS) is associated with poor clinical outcomes. However, literature provides …
syndrome (ACS) is associated with poor clinical outcomes. However, literature provides …
Basic principles of antiplatelet therapy from the perspective of new recommendations
MG Bubnova, VP Mihin - CardioSomatics, 2017 - cardiosomatics.orscience.ru
In the presented review, some of the main points of the new European recommendations on
the use of double antiplatelet therapy (DAT) and triple antithrombotic therapy in patients with …
the use of double antiplatelet therapy (DAT) and triple antithrombotic therapy in patients with …
[HTML][HTML] Основные принципы антитромбоцитарной терапии с позиции новых рекомендаций
МГ Бубнова, ВП Михин - CardioСоматика, 2017 - cyberleninka.ru
В представленном обзоре изложены некоторые основные позиции новых европейских
рекомендаций по применению двойной антитромбоцитарной терапии (ДАТ) и тройной …
рекомендаций по применению двойной антитромбоцитарной терапии (ДАТ) и тройной …
An investigation of adherence to statin therapy in patients with rheumatoid arthritis
G Binkley - 2017 - search.proquest.com
Background: Rheumatoid arthritis (RA) patients are more likely to experience a
cardiovascularevent (CVE) than the general population. This is a result of atherosclerotic …
cardiovascularevent (CVE) than the general population. This is a result of atherosclerotic …
[引用][C] Medikamentenadhärenz bei der den Fettstoffwechsel beeinflussenden medikamentösen Therapie am Beispiel der Patienten mit koronarer Herzerkrankung …
S Waßmuth - 2017 - Dissertation, Halle (Saale), Martin …
[引用][C] Utility of Acoustic Radiation Force Impulse (ARFI) Imaging of Liver and Spleen in Predicting the Variceal Status in Chronic Liver Disease
H Rao, I Siyad, A Koshy, RP Venu - Editorial Board